Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Region Zealand
University of Copenhagen
Information provided by (Responsible Party):
Dorte Nymark Brask, University Hospital Roskilde
ClinicalTrials.gov Identifier:
NCT00836524
First received: February 3, 2009
Last updated: October 27, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):